Related Experiment Video
Updated: Aug 3, 2026

Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
Effects of corticosteroids on structural cells in asthma and chronic obstructive pulmonary disease
1Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, 421 Curie Boulevard, BRB II/III, Philadelphia, PA 19104-6160, USA. rap@mail.med.upenn.edu
Abstract:
Structural cells such as airway smooth muscle, myofibroblasts, and fibroblasts play important roles in the pathogenesis of asthma and chronic obstructive pulmonary disease. Although considerable research effort has focused on the effects of steroids on leukocyte function and airway inflammation, few studies have investigated the effects of steroids on structural cell function. There is evidence that structural cells, apart from maintaining the integrity of the bronchial wall, may also participate in airway inflammatory responses. New data suggest that steroids inhibit some but not all proliferative and migratory responses in structural cells. Further, in structural cells the downstream signaling effects altered by glucocorticoids appear to differ from those observed in leukocytes. Therapeutic approaches designed to modulate chemokine and cytokine secretion by structural cells may offer new opportunities to treat diseases characterized by airway obstruction.
More Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features